The AP1M1 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the AP1M1 gene has been disrupted. This product provides a loss-of-function model for studying the adaptor protein complex 1 (AP-1) mu1 subunit in a human colorectal adenocarcinoma epithelial background. The polyclonal knockout population retains a heterogeneous mixture of edited alleles, eliminating the need for single-cell cloning and enabling direct functional assessment of AP1M1 deficiency within a genetically diverse cell pool.
The HT29 host cell line, derived from a primary tumor of a colorectal adenocarcinoma, is a well-established intestinal epithelial cell model. These adherent cells exhibit epithelial morphology and are extensively used in investigations of colorectal cancer biology, including studies of cell polarity, adhesion, and metastasis. The HT29 line retains key signaling pathways relevant to intestinal epithelial function and serves as a robust platform for interrogating the role of vesicular trafficking proteins in tumor cell behavior.
AP1M1 encodes the medium (??1) subunit of the heterotetrameric AP-1 adaptor complex, a critical component of clathrin-mediated vesicle formation at the trans-Golgi network (TGN). The ??1 subunit directly binds tyrosine-based (YXX??) and dileucine sorting motifs on cargo receptors, coupling these cargoes to clathrin coats. The AP-1 complex, activated by ARF1 and PIP2, also comprises ??1, ??, and ??1 subunits that interact with clathrin heavy chain. This machinery directs protein trafficking from the TGN to endosomes and the basolateral plasma membrane, facilitating lysosomal enzyme delivery via mannose-6-phosphate receptors and receptor recycling. Knockout of AP1M1 disrupts these sorting processes, leading to mislocalization of basolateral membrane proteins and impaired lysosomal function.
In the HT29 colorectal adenocarcinoma context, AP1M1 loss is particularly relevant for understanding polarized protein sorting in epithelial cells. Disruption of AP-1-dependent trafficking can alter the surface expression of adhesion molecules, growth factor receptors, and matrix metalloproteinases, thereby influencing cell migration and invasion??processes central to cancer metastasis. Moreover, this model recapitulates trafficking defects observed in MEDNIK syndrome, a multisystem disorder featuring mental retardation, enteropathy, deafness, and keratoderma. Thus, the AP1M1 knockout HT29 cells provide a tractable system for dissecting the molecular pathology of protein sorting diseases and metastatic progression.
This polyclonal knockout cell population is suited for diverse experimental applications, including vesicular trafficking studies, endocytosis assays, and analysis of lysosomal enzyme activity. Researchers can evaluate AP1M1-dependent cargo sorting by immunofluorescence co-staining of Golgi markers (e.g., TGN46) with endosomal markers (e.g., Rab5, Rab7) or by western blotting for cargo receptors such as the mannose-6-phosphate receptor. Functional assays for cell invasion, migration, and proliferation can assess the contribution of AP-1-mediated trafficking to metastatic phenotypes. High-content screening approaches may employ clathrin-coated vesicle isolation or pH-sensitive fluorescent cargoes to quantify trafficking kinetics. For inquiries regarding this model or other customized gene-edited products, please contact Ascent Research.
